Putting Globus Into Context: Prevalence, Characteristics, and Overlap With Other Disorders of Gut‐Brain Interaction
Karlien Raymenants, Cedric Van de Bruaene, Sawangpong Jandee, Marthe Everaert, Ami D. Sperber, Olafur Palsson, Shrikant I. Bangdiwala, Rutaba Khatun, Nathalie Rommel, Tim Vanuytsel, Jan TackABSTRACT
Objective
Globus is characterized by the sensation of a lump in the throat without dysphagia or underlying structural abnormality or major motility disorder. Reported prevalences vary considerably across studies. Globus has been linked to both heartburn and affective disorders. This study aims to determine the global prevalence of globus, its association with heartburn, overlap with disorders of gut‐brain interaction (DGBI) and psychosocial disorders, and its impact on health‐related quality of life (HRQOL).
Methods
Internet surveys from the Rome Foundation Global Epidemiology study were used ( N = 54,127). Rome IV criteria were used to identify globus and concurrent DGBI. Heartburn was defined as symptoms ≥ 2–3 days/week. Psychosocial co‐morbidity and somatic symptom severity were assessed with PHQ‐4 and PHQ‐15, and HRQOL by PROMIS‐10.
Results
The global prevalence of globus according to Rome IV criteria was 0.75%, representing 12.8% of esophageal DGBI and 1.86% of all DGBI. Prevalence was highest in Western Europe (0.94%) and Asia (0.90%), and lowest in the Middle East (0.31%). Globus was slightly more common in females (55.4%), and most affected individuals were aged between 40 and 64 years (46.6%). Coexisting heartburn was reported in 17.4% of cases, esophageal DGBI in 9.1%, and non‐esophageal DGBI in 49.0%. Anxiety and/or depression was present in 60.5%.
Conclusion
Global prevalence of globus is 0.75%, with a slight female predominance, and is most prevalent below 65 years. Overlap with non‐esophageal DGBI was greater than with heartburn symptoms or esophageal DGBI, and most patients had anxiety and/or depressive symptoms.